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Abstract
Background: The objective of this study was to evaluate the feasibility, safety, and potential benefits of
laparoscopic gastrectomy (LG) comparing with open gastrectomy (OG) in elderly population.
Methods: Studies comparing LG with OG for elderly population with gastric cancer, published between
January 1994 and July 2015, were identified in the PubMed, Embase, and ISI Web of Science databases.
Operative outcomes (intraoperative blood loss, operative time, and the number of lymph nodes harvested)
and postoperative outcomes (time to first ambulation, time to first flatus, time to first oral intake,
postoperative hospital stay, postoperative morbidity) were included and analyzed. The Newcastle-Ottawa
Scale was used to assess the quality of the pooled study. A funnel plot was used to evaluate the
publication bias.
Results: Seven studies totaling 845 patients were included in the meta-analysis. LG in comparison to OG
showed less intraoperative blood loss (weighted mean difference (WMD) −127.47; 95 % confidence interval
(CI) −202.79 to −52.16; P < 0.01), earlier time to first ambulation (WMD −2.07; 95 % CI −2.84 to −1.30;
P < 0.01), first flatus (WMD −1.04; 95 % CI −1.45 to −0.63; P < 0.01), and oral intake (WMD −0.94; 95 %
CI −1.11 to −0.77; P < 0.01), postoperative hospital stay (WMD −5.26; 95 % CI −7.58 to −2.93; P < 0.01), lower
overall postoperative complication rate (odd ratio (OR) 0.39; 95 % CI 0.28 to 0.55; P < 0.01), less surgical
complications (OR 0.47; 95 % CI 0.32 to 0.69; P < 0.01), medical complication (OR 0.35; 95 % CI 0.22 to 0.56;
P < 0.01), incisional complication (OR 0.40; 95 % CI 0.19 to 0.85; P = 0.02), and pulmonary infection (OR 0.49;
95 % CI 0.26 to 0.93; P = 0.03). No significant differences were observed between LG and OG for the
number of harvested lymph nodes. However, LG had longer operative times (WMD 15.73; 95 % CI 6.23
to 25.23; P < 0.01).
Conclusions: LG is a feasible and safe approach for elderly patients with gastric cancer. Compared with
OG, LG has less blood loss, faster postoperative recovery, and reduced postoperative morbidity.
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Background
Gastric cancer remains one of the leading causes of
cancer-related death worldwide, especially in East Asia
[1–4]. Radical gastrectomy is the mainstay of the cura-
tive treatment for gastric cancer. As life expectancy has
increased consistently, inevitably, an increasing number
of aged people with gastric cancer are anticipated to
undergo gastrectomy with the goal of radical treatment
[5]. Characteristics of elderly patients such as declining
physiological function and poor nutritional status, to-
gether with severe surgical traumas of radical gastrec-
tomy, appear to result in higher postoperative morbidity,
prolonged hospital stay, increasing financial burden, and
even higher postoperative mortality. Approaches with
less surgical traumas and milder acute inflammation
response are urged.
Despite of controversy, laparoscopic gastrectomy (LG)
has been developed as an innovation in the management
of gastric cancer [6–8]. Many previous studies including
several randomized clinical trials on LG have referred to
its surgical benefits of less invasiveness [9–12]. In
addition, recent advances in laparoscopic instruments
and accumulating surgical experience impelled surgeons
to apply LG in locally advanced gastric cancer. Growing
evidences have suggested LG was able to achieve equiva-
lent oncological outcomes as open gastrectomy (OG) in
both early and advanced gastric cancer [13, 14]. Though
concerning the pneumoperitoneum, LG has been grad-
ually performed in elderly population. Researches specific-
ally studying the application of LG in elderly population
are limited. Hence, we comprehensively collected relevant
evidences and conducted this systematic review with
meta-analysis to assess the feasibility, safety, and potential
benefits of LG in elderly population.
Methods
Search strategy
Articles published from January 1994 to July 2015 were
searched in the PubMed, Embase, and ISI Web of Science
databases. The search strategy was performed using the
following terms: “gastric cancer,” “gastric adenocarcin-
oma,” “gastric neoplasms,” “laparoscopy,” “laparoscopic,”
“elderly,” “old,” and “aged.” All abstracts retrieved from
the electronic databases were screened. Then, the full
texts were retrieved when abstracts were relevant. The
references of all relevant articles were also manually
searched for potentially relevant studies.
Study selection
Eligibility criteria included the following: (1) histologi-
cally confirmed gastric cancer; (2) published studies
comparing LG with OG for gastric cancer; (3) inclusion
of elderly patients; and (4) availability of data on infor-
mation of at least three outcome measures. Exclusion
criteria included the following: (1) recurrent gastric
cancer; (2) hand-assisted surgery or robotic surgery; (3)
combined with other malignancies; (4) abstracts pre-
sented at meetings, review articles, case report, or
letters; and (5) palliative gastrectomy. If more than
one study of a single institution existed, the study
with the most recent or the most informative data
was included unless the relevant outcomes were only
published in earlier version.
Data extraction and quality assessment
Two reviewers independently extracted and checked
data using a standard form. Disagreements in data
extraction were resolved through discussion and consen-
sus of the study team. The following data were extracted
from each study: study name, study period, sample size,
age, body mass index (BMI), comorbidity, extent of
lymph node dissection, method of gastrectomy, tumor
size, tumor location, operation time, intraoperative blood
loss, number of harvested lymph nodes, time to first
flatus, time to first oral intake, length of postoperative
hospital stay, and postoperative complications. The qual-
ities of studies were evaluated using the Newcastle-
Ottawa Quality Assessment Scale (NOS) [15]. Studies
with a score equal to or higher than six stars were
considered methodologically sound.
Statistical methods
Dichotomous variables were evaluated by using odds
ratio (OR) with a 95 % confidence interval (95 % CI),
and continuous variables were analyzed using the
weighted mean difference (WMD) with a 95 % CI. If the
study provided medians and ranges instead of means
and standard deviations (SDs), the means and SDs were
calculated using the method described by Hozo et al. [16].
Heterogeneity was evaluated by Cochran’s Q-statistic
and I2 [17]. If data was not significantly heteroge-
neous (P > 0.05 or I2 < 50 %), the pooled effects were
calculated using a fixed model [18]. Otherwise, the
pooled effects were calculated using a random-effects
model [19]. Publication bias was evaluated visually using a
funnel plot. All data were analyzed using the Review Man-
ager Version 5.0 (The Cochrane Collaboration, Oxford).
P < 0.05 was considered statistically significant.
Results
Study characteristics
The search strategy initially identified 2069 studies. After
exclusion of irrelevant studies, 20 potentially relevant
articles were obtained for assessment. Thirteen studies
were excluded due to non-comparative studies, did not
compare LG with OG, and including palliative gastrec-
tomy cases. Finally, seven studies (three from Japan and
four from China) published between 2004 and 2015
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were included [20–26]. The PRISMA flowchart of litera-
ture review is shown in Fig. 1. The characteristics of
these seven studies are summarized in Table 1. A total
of 845 patients from East Asia were pooled in this meta-
analysis: 422 in the LG group and 423 in the OG group.
Patients more than 70 years old were categorized as
elderly patients in four studies [20, 21, 24, 25], more
than 65 years old in two studies [22, 23], and more than
75 years old in one study [26]. Patients from Japan
mostly suffered early gastric cancer and underwent D1
or D1+ lymphadenectomy, while the majority of patients
from China suffered advanced gastric cancer and under-
went D2 lymphadenectomy. Three studies compared the
prognostic outcomes and demonstrated no significant
difference between LG and OG. Oncological outcomes
of included studies are showed in Table 2. All seven
studies were methodologically sound with no less than
six stars (Table 3).
Operative outcomes
All seven pooled studies reported the operation time and
intraoperative blood loss. Our meta-analysis suggested LG
was associated with a reduction in intraoperative blood loss
(WMD −127.47; 95 % CI −202.79 to −52.16; P < 0.01;
Fig. 2a), although longer operation time was also observed
(WMD 15.73; 95 % CI 6.23 to 25.23; P < 0.01; Fig. 2b).
In addition, LG achieved equivalent lymph nodes
compared with OG (WMD 1.00; 95 % CI −0.24 to
2.24; P = 0.11; Fig. 2c).
Postoperative outcomes
Patients in the LG group have earlier time to ambulation
than those in the OG group by about 2 days (WMD −2.07;
95 % CI −2.84 to −1.30; P < 0.01; Fig. 3a). The LG group
also had favored time to first flatus (WMD −1.04;
95 % CI −1.45 to −0.63; P < 0.01; Fig. 3b), time to resume
oral intake (WMD −0.94; 95 % CI −1.11 to −0.77; P < 0.01;
Fig. 3c), and postoperative hospital length (WMD −5.26;
95 % CI −7.58 to −2.93; P < 0.01; Fig. 3d).
The postoperative complications were recorded in all
studies. The LG group had lower overall postoperative
complication rate than the OG group (OR 0.39; 95 % CI
0.28 to 0.55; P < 0.01; Fig. 4a). In detail, LG comparing
with OG showed reduced surgical complications (OR
0.47; 95 % CI 0.32 to 0.69; P < 0.01; Fig. 4b) and medical
complication (OR 0.35; 95 % CI 0.22 to 0.56; P < 0.01;
Fig. 4c). Further analysis also revealed that the LG
group was associated with lower incisional complica-
tion (OR 0.40; 95 % CI 0.19 to 0.85; P = 0.02; Fig. 4d)
and pulmonary infection rate (OR 0.49; 95 % CI 0.26
to 0.93; P = 0.03; Fig. 4e).
Sensitivity analysis and publication bias
Sensitivity analyses were conducted by exclusion of the
highest weighted study in each pooled analysis. These
exclusions did not alter the results obtained in cumula-
tive analyses. Funnel plot based on the overall postoper-
ative complication was performed to assess publication
bias. No significant publication bias was detected by
visual inspection of the funnel plot in which the pooled
studies were almost symmetrical and none of them was
outside the 95 % CI (Fig. 5).
Discussion
With continuing growth of the elderly population, more
elderly patients undergo gastrectomy for gastric cancer.
Fig. 1 Flow chart of the identification and inclusion of studies
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Generally, the elderly patients are usually accompanied
with impaired physiological function, clinically present-
ing as a higher incidence of comorbidities, which is
likely to have adverse effects on perioperative outcomes
and result in postoperative complications or even death
[27, 28]. Lee et al. reported postoperative morbidity
including systemic complication, and severe complica-
tion showed higher tendency with increased age [29].
Minimally invasive and enhanced recovering approaches
are urged for this special population. Surgeons have
applied laparoscopic technique in nearly all abdominal
surgeries, including gastric cancer. However, convincing
evidences remain lacking which impels us to conduct this
meta-analysis. We found that patients who underwent LG
were associated with less blood loss, faster recovery,
and less postoperative morbidity as compared with its
open counterpart.
Postoperative complications of gastrectomy result in
several events, including longer hospital stays, increased
medical expenses, delayed adjuvant chemotherapy, and
oncological outcomes. Kubota et al. revealed that post-
operative complications that can cause prolonged in-
flammation result in shorter overall survival (OS) and
worse disease-specific mortality even if the tumor is
resected curatively [30]. One of the main concerns with
LG in elderly population is the possibility of cardiopul-
monary complication related to pneumoperitoneum.
Whereas our meta-analysis found that patients who
Table 1 Characteristics of included studies





LG OG LG OG LG OG LG OG
Yasuda 1994–2003 Japan 73 26/19 17/11 75.7 77.2 NR NR 55.60 % 67.90 % 70 abdfi
Mochiki 1998–2004 Japan 46 20/10 14/2 75.2 74.3 NR NR 43.00 % 25.00 % 70 abdei
Meng 2007–2009 China 225 88/28 107/32 71.4 71.5 21.9 22.3 49.10 % 54 % 65 abcdefghi
Hu 2007–2012 China 233 74/35 83/41 72.4 71.8 NR NR 51.40 % 54.80 % 65 abdefgh
Li 2008–2009 China 108 36/18 30/24 78.6 76.5 NR NR 85.20 % 81.50 % 70 abdg
Qiu 2012–2013 China 64 25/5 22/12 74.4 75.6 21.6 21.6 NR NR 70 abcdefgh
Suzuki 2000–2011 Japan 66 28/10 18/10 78.5 77 22.5 23 73.70 % 85.70 % 75 abcdgi
BMI body mass index, LG laparoscopic gastrectomy, OG open gastrectomy, NR not reported, a gender, b age, c BMI, d comorbidity, e tumor size, f tumor location,
g tumor stage, h type of gastrectomy, i type of anastomosis
Table 2 Oncological outcomes of included studies






Yasuda Japan LG 44/1 45/0/0 NR NR NR
OG 24/4 28/0/0 NR NR NR
Mochiki Japan LG 29/1 0/30/0 NR Median 40 m 5-year OS rate 95.7 %, 5-year DFS rate 96 %
OG 14/2 0/16/0 NR NR NR
Meng China LG 38/78 0/0/116 29 ± 11 2~48 m Median survival time 23 m
OG 41/98 0/0/139 27 ± 10 Median survival time 22.5 m
Hu China LG 24/85 0/0/109 31.4 ± 14.2 2~56 m 1-year OS rate 91.0 %, 3-year OS rate 73.7 %,
5-year OS rate 54.5 %
OG 25/99 0/0/124 32.6 ± 11.7 1-year OS rate 92.9 %, 3-year OS rate 77 %,
5-year OS rate 59.2 %
Li China LG 3/51 0/0/54 27.8 ± 3.9 36 m 1-year OS rate 85.2 %, 3-year OS rate 55.6 %
OG 5/49 0/0/54 26.7 ± 4.6 1-year OS rate 81.5 %, 3-year OS rate 57.4 %
Qiu China LG 0/30 0/0/30 30.2 ± 12.0 NR NR
OG 0/34 0/0/34 28.1 ± 11.8 NR NR
Suzuki Japan LG 37/1 6/30/2 NR Median 42 m Three died from pneumonia, one was lung
cancer-related,and one was while bathing
OG 26/2 12/12/4 NR One patient died from gastric cancer and
three died from cerebrovascular disease
EGC early gastric cancer, AGC advanced gastric cancer, LND lymph node dissection, LG laparoscopic gastrectomy, OG open gastrectomy, NR not reported, OS
overall survival, DFS disease-free survival
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Table 3 Quality assessment of included studies


















Yasuda * * * * ** * *******
Mochiki * * * * ** * * * *********
Meng * * * * ** * * ********
Hu * * * * ** * * ********
Li * * * * * * * *******
Qiu * * * * ** * *******
Suzuki * * * * ** * * ********
*It stands for one score in the assessment of study quality
Fig. 2 Meta-analyses of operative outcomes. a Intraoperative blood loss. b Operative time. c Number of harvested lymph node
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underwent LG have lower risk of medical complication,
especially the postoperative pneumonia, which was in
conformity with several reports [31]. Milder pain associ-
ated with LG encourages patients to expectorate and to
start postoperative activity earlier. Suzuki et al. also re-
ported that the cardiopulmonary adverse effects due to
pneumoperitoneum were transitory and normalized
during the intraoperative period and were acceptable
even among decrepit elderly patients having cardiopul-
monary disease [26]. Avoidance of the large incision and
completing the gastrointestinal reconstruction with or
without a mini-laparotomy reduces the risk of wound infec-
tion. Smaller incision and meticulous manipulation helped
to remit the postoperative pain and reduce surgical stress.
Okholm et al. reported that LG attenuates the postopera-
tive immune response compared to open surgery [32].
From this point, patients who underwent LG were able to
have enhanced bowel recovery. Our study also found that
the LG group had shorter bedbound time, time to first fla-
tus, time to resume oral intake, and length of hospital stay.
Fig. 3 Meta-analyses of postoperative recovery a Time to first ambulation. b Time to first flatus. c Time to first oral intake. d Postoperative
hospital stay
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Fig. 4 Meta-analyses of postoperative complication. a Overall postoperative complication. b Surgical complication. c Medical complication.
d Incisional complication. e Pulmonary infection
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In accordance with previous studies [33–35], the LG
group had a longer operation time by about 15 min in
our study. Longer operation time was considered as an
adverse factor of surgical outcomes. Miki et al. reported
that patients with extended operation time had higher
risk of severe postoperative complication [36]. Owing
to the introduction of automatic-sewn techniques and
avoidance of open and closure of conventional surgical
incision as OG, operation time of LG gradually reduced
in recent years. Several large sample studies have indi-
cated LG achieved similar or even shorter operation
time compared with OG when surgeons have passed the
learning curve [37–39], suggesting it may be a drawback
of LG no longer in the future.
As a general benefit of laparoscopic techniques, the LG
group was favored with less intraoperative blood loss.
High heterogeneity between groups was observed in our
study, which was likely to relate with the diversity of
surgeons’ experience and methods to estimate the blood
loss. This notable benefit mainly attributed to the nature
of laparoscopic techniques. Magnified operation view fa-
cilitates meticulous manipulation. On the other hand,
using harmonic instruments contribute to dissecting ves-
sels around the stomach precisely and efficiently [40]. Less
blood loss during LG may help maintain cardiopulmonary
function stability and reduced the subsequently potential
risk of postoperative morbidity.
Because none of the pooled studies reported the hazard
ratios and its 95 % CI and the Kaplan-Meier curves in sev-
eral pooled studies were of poor quality, we did not analyze
the pooled 5-year OS rate. However, all three pooled stud-
ies reported that a 5-year OS rate of LG was comparable
with OG. Though indirectly, the number of retrieved
lymph nodes is usually used as an indicator of the onco-
logic adequacy of gastrectomy. In our study, no significant
difference of retrieved lymph nodes was observed between
two groups. The number of retrieved lymph nodes in both
the LG and OG group was more than 15 as recommended
[41], which was considered to be oncologically acceptable.
The extent of lymphadenectomy remains controversial,
though D2 lymphadenectomy has been reported to yield
better prognostic outcomes [42–44]. In elderly patients,
surgeons are usually reluctant to perform D2 resection to
avoid major postoperative complications. Takeshita et al.
reported that radical lymph node dissection for elderly
patients may reduce life expectancy, especially in stage I
and II patients [27]. They also recommend that R0 resec-
tion with at least limited lymph node dissection according
to the Japanese guideline should be considered as the first
choice of treatment for this population. It was actually re-
ported that there are no significant benefits of D2 over D1
for patients >70 years old (5-year OS 19.8 % for D2 and
23.1 % for D1; P > 0.05) [45]. The average life expectancy
of elderly patients is short, which may obscure the value of
D2 lymphadenectomy. Therefore, more well-designed
studies need to evaluate the proper extent of lymph node
dissection in elderly patients.
Our studies also had some limitations, which should
be taken into consideration before clinical practices.
First, there was no randomized controlled study in-
cluded in this study. Potential bias may exist in the
selection of patients into the LG and OG group. Sec-
ond, heterogeneity in studies with different cutoff age
of elderly patients may also decrease the plausibility
of the results. Third, the overall sample size of our
study remained limited, and the inclusion of some
small sample size studies or the method to estimate
means and SDs described by Hozo may also result in
bias. Fourth, this meta-analysis only included studies
published in English or Chinese which may omit
Fig. 5 Funnel plot of meta-analysis
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some important studies in other languages. Other
biases may lie in that all pooled studies were from
East Asia while no article comparing the LG and OG from
other regions was retrieved. Nevertheless, Singh et al.
reported that Western elderly patients could also undergo
laparoscopic gastrectomy with low postoperative mor-
bidity rate (3/20), suggesting the superior safety of
LG in elderly patient [46].
Conclusions
In conclusion, LG is a feasible and safe approach for
elderly patients with gastric cancer. Compared with its
open counterpart, LG has less blood loss, faster postopera-
tive recovery, and reduced postoperative morbidity.
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